Toxoplasmic retinochoroiditis presenting in childhood: Clinical findings in a UK survey

British Journal of Ophthalmology

Volumn 90, Issue 12, 2006, Pages 1464-1467

  Stanford, M R ^a   Tan, H K ^b   Gilbert, R E ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD; CHORIORETINITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL INFECTION; HEALTH SURVEY; HUMAN; INFANT; PERINATAL PERIOD; PRIORITY JOURNAL; SEROLOGY; UNITED KINGDOM; VISUAL IMPAIRMENT;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; CHORIORETINITIS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PROGNOSIS; PROSPECTIVE STUDIES; TOXOPLASMOSIS, OCULAR; VISION DISORDERS;

EID: 33845238291     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.083543     Document Type: Article

References (24)

1. Gilbert RE, Dunn DT, Lightman S, et al. Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect 1999;123:283-9.
2. Gilbert RE, Stanford MR. Is ocular toxoplasmosis due to prenatal or postnatal infection? Br J Ophthalmol 2000;84:224-6.
3. Perkins ES. Patterns of uveitis in children. Br J Ophthalmol 1966;50:169-85.
4. Hogan MJ, Kimura SJ, O'Connor GR. Ocular toxoplasmosis. Arch Ophthalmol 1964,72:592-8.
5. Lebech M, Joynson DH, Seitz HM, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis 1996;15:799-805.
6. Mets MB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 1996;122:309-24.
7. Brezin AP, Thulliez P, Couvreur J, et al. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am J Ophthalmol 2003;135:779-84.
8. Kodjikian L, Wallon M, Fleury J, et al. Ocular manifestations in congenital toxoplasmosis. Graefe's Arch Clin Exp Ophthalmol, 2005.update from web.
9. Ades AE, Nokes DJ. Modelling age and time specific incidence from seroprevalence: toxoplasmosis. Am J Epidemiol 1993;137:1022-34.
10. Burnett AJ, Shortt SG, Isaac Renton J, et al. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 1998;108:1032-7.
11. Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol 1973;57:1-17.
12. Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in Southern Brazil. Am J Ophthalmol 1992;114:136-44.
13. Portela RWD, Bethony J, Costa MI, et al. A multihousehold study reveals a positive correlation between age, severity of ocular toxoplasmosis, and levels of glycoinositophospholipid-specific immunoglobulin A. J Infect Dis 2004;190:175-83.
14. Melamed J. The ocular features of toxoplasmosis. In: Dernouchamps JP, Verougstraete C, Caspers-Velu L, Tassignon MJ, eds. Recent advances in uveitis. Amsterdam: Kugler Publications, 1993:283-8.
15. Welton NJ, Ades AE. A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence. J R Stat Soc (C) Appl Statist 2005;54:385-404.
16. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, et al. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 2002;109:869-78.
17. Lappalainen M, Koskiniemi M, Hiilesmaa V, et al. Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. The Study Group. Pediatr Infect Dis J 1995;14:354-61.
18. Gilbert R, Gras L. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003;110:112-20.
19. Freeman K, Oakley L, Pollak A, et al. Congenital toxoplasmosis and preterm birth, low birth weight, and small for gestational age birth. BJOG 2004;112:31-7.
20. Gras L, Gilbert RE, Ades AE, et al. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol 2001;30:1309-13.
21. Binquet C, Wallon M, Quantin C, et al. Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect 2003;131:1157-68.
22. Koppe JG, Loewer Sieger DH, de Roever Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1986;i:254-6.
23. Peyron F, Wallon M, Bernardoux C. Long-term follow-up of patients with congenital ocular toxoplasmosis. N Engl J Med 1996;334:993-4.
24. Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen. J Med Screen 2002;9:135-41.